F. Budakh

F. Budach brings extensive radiation oncology leadership to RadioOnkologie im Vosspalais, after serving as Clinic Director of the Charité Clinic for Radiation Oncology until 2022. His career includes a W3 professorship call to Charité in 1993 and earlier senior physician work at the University Clinic Essen and the West German Tumor Center from 1985 to 1993. During his Charité leadership, he also supported clinical research, particularly in therapy for head and neck tumors. His scientific and clinical focus also includes sarcomas and breast carcinomas.

At the clinic, the approach reflects the same radiation oncology principles used in complex tumor care: structured planning, evidence-based treatment decisions, and careful management of acute and late side effects. For patients who require systemic therapy integration, primary radiochemotherapy is delivered as daily radiotherapy over several weeks, with alternatives considered when standard chemotherapy options are contraindicated. In those situations, radioimmunotherapy with cetuximab can be performed instead of chemo-radiation.

Education

• 1980-1985 — Specialist training for diagnostic radiology and radiation therapy, University Hospital Essen.
• 1985 — Specialist certification in radiation therapy.

Work experience

• 1980-1985 — Resident doctor; specialist training for diagnostic radiology and radiation therapy, University Hospital Essen.
• 1985-1993 — Senior Physician at the Clinic for Radiation Oncology and Radiation Therapy, University Clinic Essen; West German Tumor Center.
• 1993 — Clinic Director at Charité sites (after call to a W3 professorship).
• Until 2022 — Clinic Director of the Charité Clinic for Radiation Oncology.

Clinical focus and techniques

Budach’s radiation oncology practice is oriented toward complex oncological treatment strategies, with emphasis on tumor types such as head and neck cancers, sarcomas, and breast carcinomas.

• Primary radiochemotherapy with daily radiotherapy over several weeks.
• Radioimmunotherapy with cetuximab when contraindications to cisplatin, 5-FU, or mitomycin C exist.

Professional societies and certifications

• DEGRO — German Society for Radiation Oncology (President).

Academic output

He has acquired, managed, and published several scientific studies funded by the German Cancer Aid, with clinical focus on therapy for head and neck tumors, sarcomas, and breast carcinomas.

Courses and advanced training

• Not specified in the provided evidence.

Awards and recognition

• Not specified in the provided evidence.

At RadioOnkologie im Vosspalais in Berlin, Budach supports patients who want expert radiation oncology consultation after complex diagnoses. The clinic is located in Germany and operates as a private radiotherapy practice. Patients can request an appointment through the clinic’s contact options for consultation scheduling.